HIGHLIGHTS
- who: Riley J. Morrow and collaborators from the The Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia have published the research work: Tumor Growth Remains Refractory to Myc Ablation in Host Macrophages, in the Journal: Cells 2022, 4104 of /2022/
- what: The authors explored as a first proof-of-principle assessment whether conditional ablation of Myc in host macrophages impairs tumor growth by reducing the polarization of alternatively activated TAMs in_vivo. Assessment Cells 2022, 11, x FOR PEER REVIEW 8 of 13 of the corresponding transcripts . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.